Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hemlibra Patent Dispute Spills Over Into Patient Community

Feb 01 2018

• By Brenda Sandburg

RedBloodCellsOnWhite_1200x675

Related Content

US FDA Sought Patient Viewpoint On Hemlibra's Benefit/Risk Profile

Jan 27 2018

Genentech's Hemlibra: Clinical Outcome Assessment Data Only Partially Swayed US FDA

Jan 27 2018

Genentech Hemophilia Therapy Gets Solid Endorsement From ICER

Feb 01 2018

PCSK9 Patent Case: Praluent Injunction Vacated, But May Well Return

Oct 06 2017

‘Between A Rock And A Hard Place,’ Court Issues Injunction To Halt Praluent Sales

Jan 06 2017

Related Companies

Genentech, Inc.

Takeda Pharmaceutical Co. Ltd.

Baxalta Incorporated

Sanofi

Regeneron Pharmaceuticals, Inc.

Amgen, Inc.

Roche Holding AG

Chugai Pharmaceutical Co., Ltd.

Additional Topics

United States Policy Intellectual Property Legal Issues BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window